181 related articles for article (PubMed ID: 11072174)
1. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.
Ryynänen PM; Kortesniemi M; Coderre JA; Diaz AZ; Hiismäki P; Savolainen SE
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1145-54. PubMed ID: 11072174
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
3. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
5. Enhanced blood boron concentration estimation for BPA-F mediated BNCT.
Kortesniemi M; Seppälä T; Auterinen I; Savolainen S
Appl Radiat Isot; 2004 Nov; 61(5):823-7. PubMed ID: 15308151
[TBL] [Abstract][Full Text] [Related]
6. Long-term infusions of p-boronophenylalanine for boron neutron capture therapy: evaluation using rat brain tumor and spinal cord models.
Morris GM; Micca PL; Nawrocky MM; Weissfloch LE; Coderre JA
Radiat Res; 2002 Dec; 158(6):743-52. PubMed ID: 12452777
[TBL] [Abstract][Full Text] [Related]
7. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
[TBL] [Abstract][Full Text] [Related]
12. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Joel DD; Coderre JA; Micca PL; Nawrocky MM
J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
[TBL] [Abstract][Full Text] [Related]
13. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.
Joensuu H; Kankaanranta L; Seppälä T; Auterinen I; Kallio M; Kulvik M; Laakso J; Vähätalo J; Kortesniemi M; Kotiluoto P; Serén T; Karila J; Brander A; Järviluoma E; Ryynänen P; Paetau A; Ruokonen I; Minn H; Tenhunen M; Jääskeläinen J; Färkkilä M; Savolainen S
J Neurooncol; 2003; 62(1-2):123-34. PubMed ID: 12749708
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
16. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
18. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
[TBL] [Abstract][Full Text] [Related]
19. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
[TBL] [Abstract][Full Text] [Related]
20. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]